ITAT deleted the captive power TP adjustment, restricted the Section 14A disallowance to dividend earned, and examined the Pfizer settlement claim.
The post Ahmedabad ITAT Allows ₹602 Crore Pfizer Settlement as Business Expenditure, Holds Foreign Patent Settlement Not Hit by Explanation 1 to Section 37(1) appeared first on TaxGuru.